AZD5069

CXCR2 inhibitor · AstraZeneca

Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for AZD5069, covering 2015-05-19 to 2024-09-26. Get the full timeline:

Most recent: Clinical Trial Update: Combination Study of AZD5069 and Enzalutamide. [Phase 1, Phase 2]